MRRI Scientists and Collaborators Receive Chernowitz Medical Research Foundation Award

Carol Parlin Prushan, Vice President and Chief Development Officer, Einstein Healthcare Network; Jack Platt, Vice President and Trustee, The Chernowitz Medical Research Foundation; Dylan Edwards, PhD, Director, MRRI and Principal Investigator; and Shailesh Kantak, PhD, Institute Scientist, MRRI and Co-Principal Investigator.

George and Edith Chernowitz were pioneers in the development of quality control in scientific and industrial applications. Respected and influential service providers and technology leaders in the space program, they combined their analytical interests into developing statistical and engineering analyses of military weapons systems and related aspects of flight-related testing. Their work lives on today in applications used by all branches of the military and NASA.

Together, they created the The Chernowitz Medical Research Foundation as their legacy to enhance human health and well-being by supporting innovative research in the areas of circulatory disorders and mental health. 

The Moss Rehabilitation Research Institute (MRRI) has been awarded funding to further develop treatments for patients who have experienced a stroke. Over $400,000 from The Chernowitz Medical Research Foundation will support this MRRI-led study and conducted in collaboration with the Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital, Harvard Medical School, and Massachusetts Institute of Technology.

Led by Principal Investigator, Dylan Edwards, PhD, Director of MRRI and Director of the Human Motor Recovery Laboratory, the study titled “Precision Targeting for Transcranial Magnetic Stimulation (TMS) Treatment in Stroke Patients” will validate advanced computational TMS mapping methods for clinical and research applications including depression, neurosurgery, and stroke.

Co-Principal Investigators include Shailesh Kantak, PhD, Institute Scientist and Director of the Neuroplasticity and Motor Behavior Laboratory at MRRI and Aapo Nummenmaa, PhD, Assistant Professor of Radiology at Harvard Medical School, Assistant in Neuroscience at Massachusetts General Hospital, and Director of the TMS Core at the Martinos Center. Co-Investigators are Sergey N. Makarov, PhD, and Mohammad Daneshzand, PhD.


New Podcast Episode Discusses the Importance of Integrating Research and Clinical Care

Over the years, MossRehab has been consistently recognized as one of the nation’s top ten Best Hospitals for Rehabilitation by US News and World Report. Communication and collaboration between researchers and clinicians allows MossRehab to provide cutting-edge, evidence-based treatment to patients and ensures that scientists at the Moss Rehabilitation Research Institute (MRRI) are pursuing research topics that address critical needs in rehabilitation assessment and treatment.  

MRRI Director and Director of the Human Motor Recovery Laboratory Dylan Edwards, PhD, joins Alberto Esquenazi, MD, to discuss the importance of integrating research with clinical care in the latest episode of the MossRehab Conversations podcast. Dr. Esquenazi is the John Otto Haas Chair of Physical Medicine and Rehabilitation and Chief Medical Officer at MossRehab.  

In this episode, Drs. Edwards and Esquenazi describe the collaborative environment and other factors that drew them to Moss and have kept them here. They also share examples of programs and initiatives that MossRehab and MRRI have developed to foster interactions between scientists and clinicians, and they explain some of the impacts these efforts have on both research and clinical practice.  

You can listen to the full podcast episode or read the transcript on the MossRehab website.  


Dr. Buxbaum Receives Prestigious Freda Newcombe Prize

Moss Rehabilitation Research Institute (MRRI) is honored to announce that Laurel Buxbaum, PsyD, has recently been selected to receive the 2021 Freda Newcombe Prize from the British Neuropsychological Society (BNS). The BNS was formed in 1989 to build relationships between cognitive neuroscience and clinical investigations of patients with neuropsychological impairments. This Prize is named after Freda Newcombe, PhD, a British scientist who played a pivotal role in developing the discipline of cognitive neuropsychology. The Executive Committee of the BNS chooses one distinguished scientist annually to receive The Freda Newcombe Prize for their excellence in research. Dr. Buxbaum is now one of only fifteen scientists to have the distinction of receiving this highly competitive award. Previous recipients include renowned cognitive neuropsychologists Karalyn Patterson, PhD, Glyn Humphreys, PhD, Tim Shallice, PhD, Michael Kopelman, PhD, and Matt Lambon-Ralph, PhD.

Dr. Buxbaum is Associate Director of MRRI and Director of the Cognition and Action Laboratory at MRRI. She will be presenting her prize lecture titled “The way(s) you do the things you do: left hemisphere representation and selection of tool knowledge“ at the BNS Autumn Online meeting on Thursday November 11, 2021